These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 17022600

  • 1. [Erythropoietin-induced hypertension].
    Ioka T, Kusano E.
    Nihon Rinsho; 2006 Sep 28; Suppl 3():513-6. PubMed ID: 17022600
    [No Abstract] [Full Text] [Related]

  • 2. [Hemodialysis-associated hypertension; pathophysiology and therapy].
    Suzuki H.
    Nihon Rinsho; 2004 Jun 28; 62 Suppl 6():220-4. PubMed ID: 15250299
    [No Abstract] [Full Text] [Related]

  • 3. Erythropoietin hypertension: fact or fiction?
    Dorhout Mees EJ, Ok E.
    Int J Artif Organs; 1997 Aug 28; 20(8):415-7. PubMed ID: 9323502
    [No Abstract] [Full Text] [Related]

  • 4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 28; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M, Umezu M, Nagano M, Tagawa H.
    Clin Invest Med; 1991 Dec 28; 14(6):623-9. PubMed ID: 1794212
    [Abstract] [Full Text] [Related]

  • 6. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G, Herlitz H, Himmelmann A, Ljungman S, Aurell M.
    Lakartidningen; 1999 Nov 24; 96(47):5209-14. PubMed ID: 10608112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.
    Volpe M, Tocci G.
    Expert Rev Cardiovasc Ther; 2010 Jun 24; 8(6):811-20. PubMed ID: 20528639
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J, Ishimitsu T, Matsuoka H.
    Am J Hypertens; 2008 Feb 24; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A, Redón J.
    Med Clin (Barc); 1996 Mar 30; 106(12):457-9. PubMed ID: 8656731
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
    McCullough PA, Verrill TA.
    Postgrad Med; 2010 Mar 30; 122(2):25-34. PubMed ID: 20203453
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hypertensive syndrome in kidney diseases].
    Tareeva IE, Kutyrina IM.
    Klin Med (Mosk); 1985 Apr 30; 63(4):6-12. PubMed ID: 3897700
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renin inhibition--benefit beyond hypertension control.
    Kher V.
    J Assoc Physicians India; 2009 Jul 30; 57():518-20, 525. PubMed ID: 20329413
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR.
    Postgrad Med; 2009 Jan 30; 121(1):96-103. PubMed ID: 19179817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.